---
title: "TIMES UNI GP: RSM has been appointed as the new auditor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263468316.md"
description: "According to the Zhitong Finance APP, TIMES UNI GP announced that KPMG (Hong Kong) Limited (KPMG) has resigned as the company's auditor, effective October 30, 2025. The board has resolved to appoint RSM (Hong Kong) Limited (RSM) as the company's auditor, effective October 30, 2025, to fill the temporary vacancy left by KPMG's resignation, with a term ending at the conclusion of the company's next annual general meeting"
datetime: "2025-10-30T09:08:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263468316.md)
  - [en](https://longbridge.com/en/news/263468316.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263468316.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263468316.md) | [繁體中文](https://longbridge.com/zh-HK/news/263468316.md)


# TIMES UNI GP: RSM has been appointed as the new auditor

According to the announcement from TIMES UNI GP (02310), KPMG (Hong Kong) Limited has resigned as the company's auditor, effective from October 30, 2025.

The board, based on the recommendation of the audit committee, has decided to appoint RSM (Hong Kong) Limited as the company's auditor, effective from October 30, 2025, to fill the temporary vacancy left by KPMG's resignation, with a term ending at the conclusion of the company's next annual general meeting

### Related Stocks

- [TIMES UNI GP (02310.HK)](https://longbridge.com/en/quote/02310.HK.md)

## Related News & Research

- [China's detentions of Panama-flagged vessels raise concerns, Rubio says](https://longbridge.com/en/news/281541796.md)
- [Fosun Pharmaceutical to Set Up Parallel Fund Structure](https://longbridge.com/en/news/281297569.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/en/news/281223382.md)
- [China Seeks Reorganization of Iron Ore Market By Taking Over Mining Giants](https://longbridge.com/en/news/281532619.md)
- [Nomura Upgrades Angelalign Technology to Buy From Neutral, Adjusts Price Target to HK$79.89 From HK$66.71](https://longbridge.com/en/news/281138646.md)